The recent FDA approval of isatuximab (Sarclisa; Sanofi-Aventis) in combination with the triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) adds another option for patients with transplant-ineligible multiple myeloma. In a previous interview with The American Journal of Managed Care®, Surbhi […]
What the Approval of Isatuximab Plus VRd Adds to Multiple Myeloma Care Read More »
By optimizing the utilization of guideline-directed medical therapy (GDMT), doctors could prevent the deaths of more than a million patients with heart failure with reduced ejection fraction (HFrEF) per year.1 New research published in JAMA Cardiology revealed a startling underutilization
Optimizing GDMT Could Prevent Over 1 Million HFrEF Deaths Annually Read More »
The US health care system remains the most expensive in the world, largely funded by the federal government, state Medicaid programs, and employers. In just a decade, national health spending rose from $2.8 trillion in 2012 to $4.5 trillion in
What the Diabetes Health Economy Looks Like in 2024 Read More »
A new study from Boston University highlighted the potential of generative artificial intelligence (AI) to improve patient safety in health care. Published in The Joint Commission Journal on Quality and Patient Safety, the study tested the widely used AI model
Research Suggests AI Could Enhance Patient Safety, but Raises Questions Read More »
A new report from the National Association of Accountable Care Organizations (NAACOS) shed light on the strategies that have driven the success of ACOs in adopting value-based care (VBC). Based on in-depth interviews with high-performing ACOs, the September 2024 ACO
New Report Highlights Data-Driven Success Strategies for ACOs Read More »
A recent survey conducted by the European Society of Cardiology (ESC) revealed significant differences in the implementation of the 2021 heart failure guidelines across global health care settings, particularly in the use of guideline-directed medical therapy (GDMT) for patients with
Adherence to 2021 ESC Heart Failure Guidelines Differed Across Practices Read More »
Hospitals that score higher on a composite measure of guideline-directed medical therapy (GDMT) for patients with heart failure tend to have better patient outcomes, according to a new study published in JAMA Cardiology.1 These outcomes include reduced mortality, fewer rehospitalizations,
Study Reveals High Variability in Hospital GDMT Scores, Outcomes, Costs Read More »
A new analysis of the Family Heart Database demonstrated a link between higher lipoprotein(a) (Lp[a]) levels and continuously increased risk of atherosclerotic cardiovascular disease (ASCVD). Seth J. Baum, MD, presented new findings from the Family Heart Database | Image credit:
Largest Study of Lp(a), Recurrent ASCVD Highlights Critical Risks and Need for Screening Read More »
